| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle Proteins | 86 | 2013 | 1165 | 6.440 |
Why?
|
| Muscle, Skeletal | 66 | 2014 | 4978 | 4.040 |
Why?
|
| Sepsis | 68 | 2013 | 2610 | 3.930 |
Why?
|
| Muscular Atrophy | 17 | 2013 | 335 | 3.840 |
Why?
|
| Muscle Fibers, Skeletal | 19 | 2013 | 553 | 3.700 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 16 | 2013 | 175 | 2.870 |
Why?
|
| Dexamethasone | 23 | 2013 | 1965 | 2.860 |
Why?
|
| Multienzyme Complexes | 23 | 2004 | 665 | 2.730 |
Why?
|
| Cysteine Endopeptidases | 23 | 2008 | 542 | 2.560 |
Why?
|
| Interleukin-1 | 37 | 2004 | 1251 | 2.480 |
Why?
|
| Glucocorticoids | 28 | 2013 | 2167 | 2.360 |
Why?
|
| Interleukin-6 | 30 | 2007 | 3232 | 2.260 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 10 | 2011 | 102 | 2.230 |
Why?
|
| Intestinal Mucosa | 35 | 2002 | 3044 | 1.950 |
Why?
|
| Muscles | 55 | 2013 | 1582 | 1.890 |
Why?
|
| Ubiquitin-Protein Ligases | 20 | 2013 | 1902 | 1.860 |
Why?
|
| Calpain | 13 | 2011 | 146 | 1.820 |
Why?
|
| NF-kappa B | 20 | 2008 | 2492 | 1.710 |
Why?
|
| Ubiquitins | 23 | 2007 | 366 | 1.670 |
Why?
|
| Endotoxemia | 11 | 2002 | 198 | 1.640 |
Why?
|
| Rats | 161 | 2013 | 23786 | 1.600 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 11 | 2007 | 288 | 1.350 |
Why?
|
| Rats, Sprague-Dawley | 69 | 2013 | 8144 | 1.310 |
Why?
|
| Enterocytes | 12 | 2007 | 219 | 1.230 |
Why?
|
| Heat-Shock Response | 7 | 2002 | 179 | 1.200 |
Why?
|
| RNA, Messenger | 54 | 2013 | 12806 | 1.150 |
Why?
|
| Bacterial Infections | 25 | 2008 | 1397 | 1.130 |
Why?
|
| Protein Biosynthesis | 35 | 2013 | 2094 | 1.120 |
Why?
|
| Proteasome Endopeptidase Complex | 29 | 2011 | 1320 | 1.020 |
Why?
|
| Adenocarcinoma, Follicular | 3 | 2021 | 326 | 1.020 |
Why?
|
| Caco-2 Cells | 20 | 2007 | 367 | 1.010 |
Why?
|
| Insulin-Like Growth Factor I | 13 | 2007 | 1943 | 0.950 |
Why?
|
| Parathyroid Neoplasms | 4 | 2011 | 244 | 0.930 |
Why?
|
| Burns | 16 | 2007 | 1901 | 0.910 |
Why?
|
| Valerates | 2 | 2013 | 20 | 0.860 |
Why?
|
| Ligases | 6 | 2003 | 333 | 0.860 |
Why?
|
| Down-Regulation | 10 | 2010 | 2942 | 0.850 |
Why?
|
| Complement C3 | 8 | 2000 | 434 | 0.840 |
Why?
|
| Thyroid Neoplasms | 7 | 2021 | 2360 | 0.820 |
Why?
|
| Hyperthyroidism | 10 | 2009 | 292 | 0.810 |
Why?
|
| Arsenites | 7 | 2003 | 65 | 0.800 |
Why?
|
| Transcription Factors | 19 | 2012 | 12174 | 0.770 |
Why?
|
| Receptors, Glucocorticoid | 12 | 2013 | 309 | 0.770 |
Why?
|
| Muscle Fibers, Fast-Twitch | 4 | 2013 | 71 | 0.750 |
Why?
|
| Peptide Hydrolases | 8 | 2008 | 610 | 0.740 |
Why?
|
| Jejunum | 10 | 2000 | 475 | 0.740 |
Why?
|
| Mifepristone | 15 | 2012 | 151 | 0.740 |
Why?
|
| Liver | 45 | 2002 | 7578 | 0.710 |
Why?
|
| Animals | 212 | 2013 | 169335 | 0.710 |
Why?
|
| Smallpox | 1 | 2020 | 43 | 0.710 |
Why?
|
| I-kappa B Proteins | 7 | 2004 | 210 | 0.690 |
Why?
|
| Up-Regulation | 16 | 2013 | 4148 | 0.670 |
Why?
|
| Rats, Inbred Strains | 65 | 1992 | 2087 | 0.670 |
Why?
|
| Histone Deacetylases | 4 | 2012 | 718 | 0.650 |
Why?
|
| Amino Acids | 32 | 1999 | 1716 | 0.650 |
Why?
|
| Cachexia | 10 | 2004 | 202 | 0.640 |
Why?
|
| Forkhead Transcription Factors | 6 | 2013 | 1625 | 0.640 |
Why?
|
| Glycogen Synthase Kinase 3 | 5 | 2013 | 414 | 0.640 |
Why?
|
| Sodium Compounds | 6 | 2003 | 35 | 0.620 |
Why?
|
| Acetylation | 6 | 2012 | 1056 | 0.610 |
Why?
|
| Gene Expression Regulation | 15 | 2013 | 11932 | 0.610 |
Why?
|
| Thyroid Nodule | 3 | 2021 | 767 | 0.600 |
Why?
|
| Parathyroidectomy | 2 | 2011 | 244 | 0.590 |
Why?
|
| Cysteine Proteinase Inhibitors | 8 | 2006 | 185 | 0.590 |
Why?
|
| Leupeptins | 11 | 2003 | 113 | 0.580 |
Why?
|
| Hyperparathyroidism, Primary | 3 | 2011 | 164 | 0.580 |
Why?
|
| Adenoma | 6 | 2016 | 2163 | 0.580 |
Why?
|
| Histone Acetyltransferases | 2 | 2012 | 335 | 0.580 |
Why?
|
| Curcumin | 2 | 2008 | 97 | 0.570 |
Why?
|
| Wasting Syndrome | 2 | 2008 | 96 | 0.560 |
Why?
|
| Transcription Factor AP-1 | 4 | 2003 | 321 | 0.560 |
Why?
|
| Ubiquitin | 9 | 2013 | 843 | 0.560 |
Why?
|
| Energy Metabolism | 17 | 2016 | 2905 | 0.540 |
Why?
|
| Acetylcysteine | 4 | 2002 | 262 | 0.520 |
Why?
|
| Calcium | 15 | 2011 | 5792 | 0.520 |
Why?
|
| Immunization | 1 | 2020 | 1220 | 0.520 |
Why?
|
| Corticosterone | 14 | 2008 | 301 | 0.510 |
Why?
|
| Proteins | 21 | 2006 | 6011 | 0.490 |
Why?
|
| E1A-Associated p300 Protein | 3 | 2010 | 125 | 0.480 |
Why?
|
| Hyperparathyroidism | 3 | 2011 | 339 | 0.480 |
Why?
|
| Parathyroid Hormone | 3 | 2011 | 1803 | 0.470 |
Why?
|
| Escherichia coli Infections | 7 | 2000 | 524 | 0.460 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2013 | 179 | 0.460 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2013 | 1966 | 0.450 |
Why?
|
| Myofibrils | 13 | 2000 | 143 | 0.440 |
Why?
|
| Physician's Role | 1 | 2020 | 926 | 0.440 |
Why?
|
| Gene Expression Regulation, Enzymologic | 7 | 2010 | 1169 | 0.440 |
Why?
|
| PPAR-beta | 1 | 2013 | 4 | 0.440 |
Why?
|
| Methylhistidines | 13 | 1998 | 35 | 0.430 |
Why?
|
| Ischemia | 15 | 1991 | 1900 | 0.430 |
Why?
|
| Sirtuin 1 | 2 | 2011 | 247 | 0.430 |
Why?
|
| PPAR delta | 1 | 2013 | 40 | 0.420 |
Why?
|
| Blotting, Western | 14 | 2014 | 5033 | 0.420 |
Why?
|
| Endotoxins | 9 | 1998 | 520 | 0.420 |
Why?
|
| Cell Line | 17 | 2013 | 15604 | 0.400 |
Why?
|
| Carcinoma | 2 | 2016 | 2340 | 0.390 |
Why?
|
| Dantrolene | 2 | 2002 | 26 | 0.390 |
Why?
|
| Nerve Tissue Proteins | 7 | 2013 | 4413 | 0.390 |
Why?
|
| Glutamine | 6 | 1999 | 578 | 0.390 |
Why?
|
| Carcinoma, Papillary | 4 | 2016 | 793 | 0.380 |
Why?
|
| Caspases | 2 | 2004 | 881 | 0.380 |
Why?
|
| Male | 192 | 2021 | 365203 | 0.380 |
Why?
|
| Gene Expression | 14 | 2013 | 7603 | 0.370 |
Why?
|
| Caloric Restriction | 1 | 2013 | 301 | 0.370 |
Why?
|
| Tyrosine | 20 | 1998 | 1427 | 0.370 |
Why?
|
| Physical Endurance | 1 | 2013 | 370 | 0.360 |
Why?
|
| Tumor Necrosis Factor-alpha | 17 | 2001 | 4356 | 0.360 |
Why?
|
| Stilbenes | 1 | 2011 | 155 | 0.360 |
Why?
|
| Disease Outbreaks | 1 | 2020 | 1761 | 0.360 |
Why?
|
| Transcription, Genetic | 12 | 2011 | 7609 | 0.360 |
Why?
|
| RNA, Small Interfering | 9 | 2013 | 3433 | 0.360 |
Why?
|
| Heat-Shock Proteins | 5 | 2007 | 797 | 0.360 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2012 | 1811 | 0.340 |
Why?
|
| Physical Conditioning, Animal | 1 | 2013 | 363 | 0.340 |
Why?
|
| Enzyme Inhibitors | 11 | 2006 | 3726 | 0.340 |
Why?
|
| Phospholipases A2 | 1 | 2010 | 197 | 0.340 |
Why?
|
| Metoprolol | 8 | 1987 | 90 | 0.330 |
Why?
|
| Myostatin | 1 | 2010 | 129 | 0.330 |
Why?
|
| Muscle Fibers, Slow-Twitch | 3 | 1999 | 52 | 0.330 |
Why?
|
| Mitogen-Activated Protein Kinases | 6 | 2004 | 1246 | 0.320 |
Why?
|
| Leucine | 14 | 2007 | 548 | 0.320 |
Why?
|
| Wounds and Injuries | 9 | 2008 | 2517 | 0.320 |
Why?
|
| Phosphorylation | 6 | 2013 | 8317 | 0.310 |
Why?
|
| Biopsy, Fine-Needle | 3 | 2021 | 1132 | 0.310 |
Why?
|
| Serum Amyloid A Protein | 2 | 1998 | 128 | 0.310 |
Why?
|
| Dinoprostone | 8 | 1997 | 597 | 0.300 |
Why?
|
| Trans-Activators | 2 | 2010 | 2858 | 0.300 |
Why?
|
| Hormone Antagonists | 6 | 2010 | 108 | 0.300 |
Why?
|
| Muscle Strength | 1 | 2012 | 641 | 0.300 |
Why?
|
| Lactones | 3 | 2006 | 316 | 0.300 |
Why?
|
| Cell Size | 3 | 2012 | 626 | 0.300 |
Why?
|
| Dose-Response Relationship, Drug | 16 | 2008 | 10765 | 0.290 |
Why?
|
| Indomethacin | 7 | 1995 | 323 | 0.290 |
Why?
|
| Blotting, Northern | 9 | 2000 | 1553 | 0.290 |
Why?
|
| Oligopeptides | 4 | 2004 | 1194 | 0.290 |
Why?
|
| Mice, Inbred A | 7 | 2000 | 245 | 0.280 |
Why?
|
| Epithelial Cells | 6 | 2002 | 3702 | 0.280 |
Why?
|
| Cell Nucleus | 9 | 2013 | 2885 | 0.270 |
Why?
|
| Cells, Cultured | 20 | 2014 | 19023 | 0.270 |
Why?
|
| Digestive System | 2 | 2000 | 244 | 0.270 |
Why?
|
| Cecum | 13 | 2002 | 231 | 0.270 |
Why?
|
| Polyamines | 3 | 1996 | 133 | 0.270 |
Why?
|
| CCAAT-Enhancer-Binding Protein-delta | 5 | 2005 | 26 | 0.270 |
Why?
|
| Cycloheximide | 4 | 2004 | 341 | 0.270 |
Why?
|
| Intestine, Small | 5 | 2002 | 1218 | 0.260 |
Why?
|
| Ligation | 16 | 2002 | 446 | 0.250 |
Why?
|
| Triiodothyronine | 8 | 1987 | 492 | 0.250 |
Why?
|
| Thyroidectomy | 8 | 2021 | 914 | 0.250 |
Why?
|
| DNA-Binding Proteins | 8 | 2010 | 9618 | 0.250 |
Why?
|
| Calcium Signaling | 1 | 2010 | 738 | 0.250 |
Why?
|
| Lysosomes | 4 | 2009 | 940 | 0.240 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2008 | 693 | 0.240 |
Why?
|
| Hot Temperature | 5 | 2003 | 1441 | 0.240 |
Why?
|
| Calcimycin | 1 | 2004 | 214 | 0.240 |
Why?
|
| Hyperthermia, Induced | 3 | 2002 | 416 | 0.230 |
Why?
|
| Adrenergic beta-Antagonists | 5 | 1988 | 1243 | 0.230 |
Why?
|
| Stress, Physiological | 2 | 2002 | 1408 | 0.220 |
Why?
|
| Nutrition Disorders | 2 | 2002 | 204 | 0.220 |
Why?
|
| Muscle Relaxants, Central | 2 | 2002 | 93 | 0.220 |
Why?
|
| Liver Circulation | 8 | 1987 | 159 | 0.220 |
Why?
|
| Permeability | 3 | 2002 | 726 | 0.220 |
Why?
|
| Probiotics | 1 | 2007 | 383 | 0.220 |
Why?
|
| HSP70 Heat-Shock Proteins | 5 | 2007 | 395 | 0.220 |
Why?
|
| Lipopolysaccharides | 7 | 2002 | 2222 | 0.220 |
Why?
|
| Calcium-Binding Proteins | 2 | 2006 | 1083 | 0.210 |
Why?
|
| Transfection | 7 | 2006 | 5763 | 0.210 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2004 | 492 | 0.210 |
Why?
|
| Ubiquitination | 1 | 2007 | 1010 | 0.210 |
Why?
|
| Histidine | 3 | 1990 | 302 | 0.210 |
Why?
|
| DNA | 12 | 2006 | 7214 | 0.200 |
Why?
|
| Electrophoretic Mobility Shift Assay | 4 | 2004 | 294 | 0.200 |
Why?
|
| Ornithine Decarboxylase | 4 | 1996 | 63 | 0.200 |
Why?
|
| Recombinant Proteins | 18 | 2002 | 6512 | 0.200 |
Why?
|
| Cytokines | 11 | 2004 | 7453 | 0.200 |
Why?
|
| Thiocarbamates | 3 | 2000 | 30 | 0.200 |
Why?
|
| Humans | 113 | 2021 | 768970 | 0.190 |
Why?
|
| Glycoproteins | 2 | 2006 | 2202 | 0.190 |
Why?
|
| RNA-Binding Proteins | 1 | 2010 | 1891 | 0.190 |
Why?
|
| General Surgery | 2 | 2004 | 1722 | 0.190 |
Why?
|
| Interleukin-1beta | 1 | 2007 | 1026 | 0.190 |
Why?
|
| Gastrointestinal Hormones | 3 | 2002 | 101 | 0.190 |
Why?
|
| Flavonoids | 5 | 2005 | 447 | 0.180 |
Why?
|
| Insulin | 10 | 2007 | 6610 | 0.180 |
Why?
|
| Shock | 2 | 2002 | 316 | 0.180 |
Why?
|
| Base Sequence | 10 | 2005 | 12430 | 0.180 |
Why?
|
| Intestinal Absorption | 1 | 2001 | 400 | 0.170 |
Why?
|
| Putrescine | 3 | 1996 | 42 | 0.170 |
Why?
|
| Serine Endopeptidases | 2 | 2002 | 1027 | 0.170 |
Why?
|
| Peritonitis | 3 | 2013 | 368 | 0.170 |
Why?
|
| DNA Primers | 5 | 2005 | 2827 | 0.170 |
Why?
|
| History, 18th Century | 1 | 2020 | 206 | 0.170 |
Why?
|
| Interleukin-10 | 2 | 2002 | 1183 | 0.170 |
Why?
|
| Coumarins | 1 | 2000 | 119 | 0.170 |
Why?
|
| MAP Kinase Signaling System | 3 | 2005 | 1495 | 0.170 |
Why?
|
| Transcription Factor CHOP | 3 | 2006 | 69 | 0.170 |
Why?
|
| Diagnostic Errors | 1 | 2007 | 1281 | 0.170 |
Why?
|
| Dipeptides | 3 | 2006 | 386 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 8664 | 0.160 |
Why?
|
| Propranolol | 5 | 1987 | 493 | 0.160 |
Why?
|
| Mass Vaccination | 1 | 2020 | 111 | 0.160 |
Why?
|
| Cathepsin L | 2 | 2009 | 69 | 0.160 |
Why?
|
| Adipose Tissue, Brown | 2 | 2016 | 776 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2010 | 4592 | 0.160 |
Why?
|
| Dysphonia | 1 | 2021 | 144 | 0.160 |
Why?
|
| Hepatic Artery | 6 | 1985 | 232 | 0.160 |
Why?
|
| Transcriptional Activation | 3 | 2002 | 1750 | 0.160 |
Why?
|
| Hindlimb | 7 | 2005 | 516 | 0.150 |
Why?
|
| p300-CBP Transcription Factors | 2 | 2012 | 148 | 0.150 |
Why?
|
| Keto Acids | 2 | 1988 | 34 | 0.150 |
Why?
|
| Cyclic AMP | 1 | 2002 | 1469 | 0.150 |
Why?
|
| Breast | 2 | 2000 | 1976 | 0.150 |
Why?
|
| RNA Interference | 3 | 2012 | 2835 | 0.150 |
Why?
|
| Mice | 23 | 2013 | 82072 | 0.150 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2003 | 621 | 0.150 |
Why?
|
| Methimazole | 2 | 1987 | 41 | 0.140 |
Why?
|
| Phenylalanine | 8 | 1998 | 368 | 0.140 |
Why?
|
| Cell Cycle Proteins | 2 | 2006 | 3450 | 0.140 |
Why?
|
| Neurosecretory Systems | 1 | 1999 | 223 | 0.140 |
Why?
|
| HSP72 Heat-Shock Proteins | 3 | 2002 | 40 | 0.140 |
Why?
|
| Muscular Diseases | 2 | 2000 | 553 | 0.140 |
Why?
|
| Mice, Inbred Strains | 4 | 2002 | 1769 | 0.140 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 1996 | 480 | 0.140 |
Why?
|
| Hydrolysis | 4 | 2002 | 646 | 0.140 |
Why?
|
| Adenosine Triphosphate | 11 | 1998 | 2003 | 0.140 |
Why?
|
| Thiadiazoles | 3 | 2005 | 63 | 0.140 |
Why?
|
| Lithium Chloride | 3 | 2005 | 83 | 0.140 |
Why?
|
| Surgical Wound Infection | 6 | 1984 | 1547 | 0.140 |
Why?
|
| Antithyroid Agents | 2 | 1988 | 72 | 0.140 |
Why?
|
| Enzyme Activation | 5 | 2011 | 3588 | 0.140 |
Why?
|
| Time Factors | 21 | 2021 | 40261 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 3 | 2002 | 5801 | 0.130 |
Why?
|
| Apolipoproteins | 1 | 1998 | 328 | 0.130 |
Why?
|
| Carcinoma, Lobular | 1 | 2000 | 480 | 0.130 |
Why?
|
| Sialoglycoproteins | 2 | 1994 | 320 | 0.130 |
Why?
|
| Thyrotoxicosis | 1 | 2016 | 85 | 0.130 |
Why?
|
| Nuclear Proteins | 3 | 2007 | 5804 | 0.130 |
Why?
|
| Dactinomycin | 3 | 2004 | 305 | 0.130 |
Why?
|
| Turpentine | 1 | 1995 | 10 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 6 | 2005 | 6086 | 0.130 |
Why?
|
| Hydroxamic Acids | 2 | 2010 | 483 | 0.130 |
Why?
|
| Nutritional Support | 3 | 2002 | 178 | 0.120 |
Why?
|
| Tritium | 5 | 2002 | 707 | 0.120 |
Why?
|
| Caspase 3 | 2 | 2009 | 731 | 0.120 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 3 | 2000 | 198 | 0.120 |
Why?
|
| Peptide Biosynthesis | 1 | 1994 | 52 | 0.120 |
Why?
|
| Interferon-gamma | 3 | 1997 | 3163 | 0.120 |
Why?
|
| Amino Acid Oxidoreductases | 2 | 1994 | 149 | 0.120 |
Why?
|
| Temperature | 4 | 2003 | 2235 | 0.120 |
Why?
|
| Thermogenesis | 2 | 2016 | 494 | 0.120 |
Why?
|
| Ileum | 4 | 2001 | 558 | 0.120 |
Why?
|
| Preoperative Care | 7 | 1995 | 2258 | 0.120 |
Why?
|
| Protein Isoforms | 3 | 2006 | 1714 | 0.120 |
Why?
|
| Quercetin | 2 | 2007 | 97 | 0.120 |
Why?
|
| Acute-Phase Proteins | 6 | 1996 | 252 | 0.120 |
Why?
|
| Interleukins | 2 | 1997 | 796 | 0.110 |
Why?
|
| Aminoisobutyric Acids | 8 | 1993 | 39 | 0.110 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1994 | 179 | 0.110 |
Why?
|
| Prostaglandins E | 3 | 1988 | 166 | 0.110 |
Why?
|
| Hemodynamics | 5 | 1990 | 4199 | 0.110 |
Why?
|
| Methylprednisolone | 2 | 1986 | 386 | 0.110 |
Why?
|
| Receptors, Interleukin-1 | 1 | 1994 | 260 | 0.110 |
Why?
|
| Serum Response Factor | 1 | 2013 | 78 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 5 | 2002 | 6131 | 0.110 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2000 | 1093 | 0.110 |
Why?
|
| Reactive Oxygen Species | 2 | 2002 | 2149 | 0.110 |
Why?
|
| Middle Aged | 41 | 2021 | 223737 | 0.110 |
Why?
|
| Organ Size | 5 | 2010 | 2268 | 0.100 |
Why?
|
| Serum Albumin | 2 | 1995 | 677 | 0.100 |
Why?
|
| Protein Binding | 5 | 2005 | 9344 | 0.100 |
Why?
|
| Repressor Proteins | 1 | 2003 | 2986 | 0.100 |
Why?
|
| Muscle Cells | 1 | 2013 | 195 | 0.100 |
Why?
|
| Escherichia coli | 6 | 2007 | 4213 | 0.100 |
Why?
|
| Cathepsin B | 4 | 1998 | 80 | 0.100 |
Why?
|
| Reference Values | 10 | 1998 | 4940 | 0.100 |
Why?
|
| Actomyosin | 1 | 2012 | 114 | 0.100 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 2 | 2002 | 88 | 0.100 |
Why?
|
| Nitric Oxide | 3 | 1995 | 2149 | 0.100 |
Why?
|
| Hypothyroidism | 1 | 2016 | 667 | 0.100 |
Why?
|
| Aminopeptidases | 2 | 2002 | 114 | 0.090 |
Why?
|
| Nutrition Assessment | 1 | 1995 | 740 | 0.090 |
Why?
|
| Thyroxine | 4 | 1988 | 665 | 0.090 |
Why?
|
| Amino Acids, Branched-Chain | 3 | 1988 | 268 | 0.090 |
Why?
|
| Liver Diseases | 3 | 1995 | 1305 | 0.090 |
Why?
|
| Luciferases | 2 | 2003 | 713 | 0.090 |
Why?
|
| Shock, Septic | 4 | 1996 | 774 | 0.090 |
Why?
|
| Chloralose | 1 | 1990 | 14 | 0.090 |
Why?
|
| Myogenin | 1 | 2010 | 54 | 0.090 |
Why?
|
| Gastric Mucosa | 3 | 2000 | 602 | 0.090 |
Why?
|
| Parathyroid Glands | 1 | 1992 | 522 | 0.090 |
Why?
|
| Adenine Nucleotides | 5 | 1990 | 110 | 0.090 |
Why?
|
| Culture Techniques | 4 | 2001 | 530 | 0.090 |
Why?
|
| Punctures | 6 | 1998 | 372 | 0.090 |
Why?
|
| Smad Proteins | 1 | 2010 | 157 | 0.090 |
Why?
|
| Pentobarbital | 1 | 1990 | 153 | 0.090 |
Why?
|
| Aged | 31 | 2021 | 171786 | 0.080 |
Why?
|
| MyoD Protein | 1 | 2010 | 143 | 0.080 |
Why?
|
| Arachidonic Acids | 1 | 1990 | 296 | 0.080 |
Why?
|
| Follistatin | 1 | 2010 | 138 | 0.080 |
Why?
|
| Colon | 4 | 2000 | 1803 | 0.080 |
Why?
|
| Neoplasms | 4 | 2011 | 22389 | 0.080 |
Why?
|
| Hydrogen Peroxide | 2 | 2006 | 742 | 0.080 |
Why?
|
| Signal Transduction | 9 | 2014 | 23653 | 0.080 |
Why?
|
| Aneurysm | 3 | 1985 | 343 | 0.080 |
Why?
|
| Muscle Weakness | 1 | 2012 | 413 | 0.080 |
Why?
|
| Neoplasms, Multiple Primary | 2 | 2002 | 592 | 0.080 |
Why?
|
| Activins | 1 | 2010 | 211 | 0.080 |
Why?
|
| Cell Survival | 4 | 2003 | 5793 | 0.080 |
Why?
|
| Postoperative Complications | 7 | 2021 | 15889 | 0.080 |
Why?
|
| Retrospective Studies | 9 | 2021 | 81903 | 0.080 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 2009 | 184 | 0.080 |
Why?
|
| Tissue Culture Techniques | 1 | 2010 | 290 | 0.080 |
Why?
|
| Tosyllysine Chloromethyl Ketone | 2 | 1999 | 5 | 0.080 |
Why?
|
| Female | 49 | 2021 | 397515 | 0.080 |
Why?
|
| Antibodies | 1 | 1997 | 2422 | 0.080 |
Why?
|
| Molecular Sequence Data | 6 | 1996 | 17629 | 0.080 |
Why?
|
| Adult | 31 | 2021 | 223851 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2006 | 2474 | 0.080 |
Why?
|
| Acute-Phase Reaction | 2 | 2000 | 91 | 0.080 |
Why?
|
| Biopsy, Needle | 1 | 1993 | 1626 | 0.080 |
Why?
|
| Intraoperative Period | 1 | 2009 | 513 | 0.080 |
Why?
|
| Diagnosis, Differential | 4 | 2016 | 13021 | 0.080 |
Why?
|
| Glutamate-Ammonia Ligase | 2 | 1999 | 76 | 0.070 |
Why?
|
| Genistein | 2 | 1999 | 87 | 0.070 |
Why?
|
| Kinetics | 5 | 2001 | 6332 | 0.070 |
Why?
|
| Pyrrolidines | 3 | 2000 | 341 | 0.070 |
Why?
|
| Short Bowel Syndrome | 2 | 2002 | 353 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2000 | 3813 | 0.070 |
Why?
|
| Neck Dissection | 1 | 2009 | 201 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2008 | 2460 | 0.070 |
Why?
|
| Injections, Intraperitoneal | 2 | 2001 | 412 | 0.070 |
Why?
|
| Luminescent Measurements | 1 | 2009 | 342 | 0.070 |
Why?
|
| Premedication | 2 | 1988 | 246 | 0.070 |
Why?
|
| Hypercalcemia | 2 | 1992 | 424 | 0.070 |
Why?
|
| Nitrogen | 2 | 1988 | 345 | 0.070 |
Why?
|
| Mammography | 2 | 2000 | 2434 | 0.070 |
Why?
|
| Fasting | 2 | 2010 | 1610 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 1608 | 0.070 |
Why?
|
| Glutathione | 1 | 1990 | 589 | 0.070 |
Why?
|
| Allopurinol | 2 | 1986 | 202 | 0.070 |
Why?
|
| Disease Models, Animal | 8 | 2010 | 18354 | 0.070 |
Why?
|
| Cytoplasm | 2 | 2003 | 1505 | 0.070 |
Why?
|
| Epithelium | 3 | 1997 | 1607 | 0.070 |
Why?
|
| Analysis of Variance | 5 | 2000 | 6236 | 0.070 |
Why?
|
| Cathepsins | 1 | 2008 | 242 | 0.070 |
Why?
|
| Nitroarginine | 3 | 1995 | 66 | 0.070 |
Why?
|
| Carcinoma, Medullary | 1 | 2007 | 116 | 0.070 |
Why?
|
| Sweden | 4 | 2004 | 1382 | 0.070 |
Why?
|
| Pepstatins | 1 | 2006 | 10 | 0.070 |
Why?
|
| Diethylcarbamazine | 1 | 1986 | 23 | 0.070 |
Why?
|
| Leptin | 1 | 2014 | 1597 | 0.070 |
Why?
|
| Arginine | 3 | 1995 | 932 | 0.070 |
Why?
|
| Shock, Traumatic | 1 | 1986 | 22 | 0.070 |
Why?
|
| Protease Inhibitors | 3 | 2004 | 752 | 0.070 |
Why?
|
| Atrophy | 1 | 2011 | 1647 | 0.060 |
Why?
|
| Thyrotropin | 1 | 2009 | 834 | 0.060 |
Why?
|
| Lactobacillus | 1 | 2007 | 212 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2005 | 2884 | 0.060 |
Why?
|
| Models, Biological | 4 | 2007 | 9499 | 0.060 |
Why?
|
| Myoblasts, Skeletal | 1 | 2006 | 74 | 0.060 |
Why?
|
| Thymidine | 2 | 1997 | 297 | 0.060 |
Why?
|
| Thiazoles | 1 | 2013 | 1542 | 0.060 |
Why?
|
| Sarcomeres | 1 | 2008 | 380 | 0.060 |
Why?
|
| Toes | 2 | 2005 | 209 | 0.060 |
Why?
|
| Dextrans | 3 | 2002 | 574 | 0.060 |
Why?
|
| Radionuclide Imaging | 1 | 2009 | 1998 | 0.060 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2010 | 778 | 0.060 |
Why?
|
| Horseradish Peroxidase | 2 | 2002 | 170 | 0.060 |
Why?
|
| History, 20th Century | 2 | 2004 | 2771 | 0.060 |
Why?
|
| Cefuroxime | 1 | 1984 | 23 | 0.060 |
Why?
|
| Biological Transport | 7 | 1999 | 2085 | 0.060 |
Why?
|
| DNA, Complementary | 2 | 1999 | 1990 | 0.060 |
Why?
|
| Fluorescein-5-isothiocyanate | 2 | 2002 | 222 | 0.060 |
Why?
|
| Perfusion | 6 | 2001 | 1402 | 0.060 |
Why?
|
| Wounds, Stab | 2 | 1983 | 72 | 0.060 |
Why?
|
| Adaptation, Biological | 2 | 2002 | 147 | 0.060 |
Why?
|
| Hydralazine | 1 | 1984 | 34 | 0.060 |
Why?
|
| Molecular Probes | 2 | 1996 | 309 | 0.060 |
Why?
|
| Lactic Acid | 4 | 1997 | 1140 | 0.060 |
Why?
|
| Protein Transport | 1 | 2010 | 1956 | 0.060 |
Why?
|
| Organ Specificity | 2 | 2000 | 1970 | 0.060 |
Why?
|
| Wounds, Gunshot | 4 | 1984 | 588 | 0.060 |
Why?
|
| Exostoses, Multiple Hereditary | 1 | 1983 | 29 | 0.060 |
Why?
|
| Colchicine | 2 | 1998 | 257 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2010 | 1505 | 0.050 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 2003 | 88 | 0.050 |
Why?
|
| Prospective Studies | 10 | 2011 | 54962 | 0.050 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2004 | 412 | 0.050 |
Why?
|
| Cephalosporins | 1 | 1984 | 200 | 0.050 |
Why?
|
| Reperfusion Injury | 1 | 1990 | 1036 | 0.050 |
Why?
|
| Reoperation | 2 | 2009 | 4342 | 0.050 |
Why?
|
| Colonic Diseases | 1 | 1984 | 204 | 0.050 |
Why?
|
| Phosphates | 1 | 2006 | 765 | 0.050 |
Why?
|
| Boston | 1 | 2016 | 9377 | 0.050 |
Why?
|
| Ascitic Fluid | 2 | 2001 | 189 | 0.050 |
Why?
|
| Oxygen | 2 | 1988 | 4272 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3118 | 0.050 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 874 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3241 | 0.050 |
Why?
|
| Chymotrypsin | 1 | 2002 | 137 | 0.050 |
Why?
|
| Cholecystokinin | 1 | 2002 | 115 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2006 | 2298 | 0.050 |
Why?
|
| Leg | 2 | 1984 | 1089 | 0.050 |
Why?
|
| Random Allocation | 5 | 1987 | 2394 | 0.050 |
Why?
|
| Hemobilia | 1 | 1981 | 18 | 0.050 |
Why?
|
| Body Weight | 7 | 2004 | 4628 | 0.050 |
Why?
|
| Incidence | 3 | 2016 | 21547 | 0.050 |
Why?
|
| Aged, 80 and over | 7 | 2021 | 59739 | 0.050 |
Why?
|
| Granular Cell Tumor | 1 | 2002 | 48 | 0.050 |
Why?
|
| Bacterial Translocation | 1 | 2002 | 74 | 0.050 |
Why?
|
| Radiopharmaceuticals | 2 | 2009 | 2734 | 0.050 |
Why?
|
| Ultrasonography | 3 | 2009 | 6002 | 0.050 |
Why?
|
| Thyroid Gland | 1 | 1988 | 1171 | 0.050 |
Why?
|
| Surgical Instruments | 1 | 1984 | 386 | 0.050 |
Why?
|
| Radioligand Assay | 1 | 2002 | 366 | 0.050 |
Why?
|
| Genes, erbB-2 | 1 | 2002 | 162 | 0.050 |
Why?
|
| Enzyme Stability | 1 | 2002 | 219 | 0.050 |
Why?
|
| Plasmids | 1 | 2006 | 2269 | 0.050 |
Why?
|
| Popliteal Artery | 1 | 1983 | 313 | 0.050 |
Why?
|
| History, 19th Century | 1 | 2004 | 715 | 0.050 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 2021 | 86 | 0.050 |
Why?
|
| Colony Count, Microbial | 1 | 2001 | 328 | 0.050 |
Why?
|
| Ribosomes | 3 | 1984 | 499 | 0.050 |
Why?
|
| Heat Stress Disorders | 1 | 2002 | 80 | 0.050 |
Why?
|
| Breast Neoplasms | 4 | 2002 | 21188 | 0.040 |
Why?
|
| Superoxide Dismutase | 3 | 1988 | 595 | 0.040 |
Why?
|
| Trauma Severity Indices | 1 | 2002 | 479 | 0.040 |
Why?
|
| Quinones | 1 | 2000 | 78 | 0.040 |
Why?
|
| Pancreatitis, Acute Necrotizing | 1 | 2002 | 174 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2005 | 4528 | 0.040 |
Why?
|
| Stomach Neoplasms | 1 | 2011 | 1483 | 0.040 |
Why?
|
| Shock, Hemorrhagic | 2 | 1980 | 224 | 0.040 |
Why?
|
| Palpation | 1 | 2000 | 166 | 0.040 |
Why?
|
| Hormones | 3 | 1990 | 870 | 0.040 |
Why?
|
| Thyroid Hormones | 2 | 2016 | 407 | 0.040 |
Why?
|
| Dogs | 7 | 1984 | 3845 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 8749 | 0.040 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2002 | 500 | 0.040 |
Why?
|
| Sulfhydryl Reagents | 1 | 1999 | 29 | 0.040 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2003 | 423 | 0.040 |
Why?
|
| Benzoquinones | 1 | 2000 | 198 | 0.040 |
Why?
|
| Intestines | 2 | 2000 | 1911 | 0.040 |
Why?
|
| Ouabain | 2 | 1996 | 246 | 0.040 |
Why?
|
| Chlorides | 1 | 2002 | 666 | 0.040 |
Why?
|
| Regeneration | 1 | 2008 | 1524 | 0.040 |
Why?
|
| Debridement | 1 | 2002 | 494 | 0.040 |
Why?
|
| Voice Quality | 1 | 2021 | 226 | 0.040 |
Why?
|
| Adenosylmethionine Decarboxylase | 2 | 1996 | 11 | 0.040 |
Why?
|
| Cell Membrane Permeability | 1 | 2001 | 573 | 0.040 |
Why?
|
| Glucagon | 4 | 1990 | 535 | 0.040 |
Why?
|
| Weight Loss | 1 | 2011 | 2721 | 0.040 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 1999 | 361 | 0.040 |
Why?
|
| Biological Transport, Active | 2 | 1997 | 323 | 0.040 |
Why?
|
| Spermidine | 2 | 1996 | 63 | 0.040 |
Why?
|
| Spermine | 2 | 1996 | 70 | 0.040 |
Why?
|
| Lactates | 7 | 1991 | 401 | 0.040 |
Why?
|
| Cholangiography | 1 | 1999 | 182 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2006 | 1667 | 0.040 |
Why?
|
| Cathepsin D | 1 | 1998 | 59 | 0.040 |
Why?
|
| Lactams, Macrocyclic | 1 | 2000 | 319 | 0.040 |
Why?
|
| Transaminases | 2 | 1997 | 199 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2005 | 1611 | 0.040 |
Why?
|
| Nutritional Status | 2 | 1999 | 1627 | 0.040 |
Why?
|
| Infusions, Parenteral | 1 | 1998 | 396 | 0.040 |
Why?
|
| Interleukin-4 | 1 | 2002 | 1157 | 0.040 |
Why?
|
| Adrenal Glands | 2 | 1993 | 557 | 0.040 |
Why?
|
| Magnesium | 1 | 1982 | 816 | 0.040 |
Why?
|
| Imidazoles | 1 | 2004 | 1169 | 0.040 |
Why?
|
| Critical Illness | 1 | 2011 | 2754 | 0.040 |
Why?
|
| Body Surface Area | 1 | 1998 | 206 | 0.040 |
Why?
|
| Deoxyglucose | 1 | 1998 | 333 | 0.040 |
Why?
|
| Epinephrine | 4 | 1990 | 794 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2000 | 581 | 0.040 |
Why?
|
| Starvation | 2 | 1989 | 141 | 0.040 |
Why?
|
| Mannitol | 1 | 1998 | 177 | 0.040 |
Why?
|
| Methylamines | 1 | 1998 | 136 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 2002 | 842 | 0.040 |
Why?
|
| Cushing Syndrome | 1 | 1999 | 241 | 0.040 |
Why?
|
| Tuberculosis, Female Genital | 1 | 1977 | 2 | 0.040 |
Why?
|
| Cytodiagnosis | 1 | 2021 | 453 | 0.040 |
Why?
|
| Nitrites | 2 | 1994 | 156 | 0.030 |
Why?
|
| Glutaminase | 1 | 1997 | 32 | 0.030 |
Why?
|
| Chloroquine | 1 | 1998 | 276 | 0.030 |
Why?
|
| Pneumatosis Cystoides Intestinalis | 1 | 1977 | 31 | 0.030 |
Why?
|
| Endometritis | 1 | 1977 | 49 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 9549 | 0.030 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 1999 | 236 | 0.030 |
Why?
|
| Femur | 1 | 1983 | 1321 | 0.030 |
Why?
|
| Carcinoma in Situ | 2 | 2000 | 788 | 0.030 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 2 | 2002 | 933 | 0.030 |
Why?
|
| Brain Diseases | 1 | 1986 | 1558 | 0.030 |
Why?
|
| Eflornithine | 1 | 1996 | 31 | 0.030 |
Why?
|
| Growth Hormone | 1 | 1999 | 573 | 0.030 |
Why?
|
| Cholecystectomy | 1 | 1999 | 409 | 0.030 |
Why?
|
| DNA Damage | 1 | 2006 | 2472 | 0.030 |
Why?
|
| Hospitals, Veterans | 1 | 1999 | 395 | 0.030 |
Why?
|
| Isoflavones | 1 | 1997 | 139 | 0.030 |
Why?
|
| Albumins | 4 | 1992 | 577 | 0.030 |
Why?
|
| Nitrates | 2 | 1994 | 260 | 0.030 |
Why?
|
| Pancreatitis | 2 | 1999 | 1087 | 0.030 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 1997 | 174 | 0.030 |
Why?
|
| United States | 2 | 2020 | 73186 | 0.030 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 2 | 1994 | 299 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1996 | 417 | 0.030 |
Why?
|
| Dopamine | 1 | 1983 | 1596 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2002 | 1111 | 0.030 |
Why?
|
| Vascular Surgical Procedures | 1 | 1984 | 1515 | 0.030 |
Why?
|
| Oxygen Consumption | 4 | 2013 | 1883 | 0.030 |
Why?
|
| Uterine Neoplasms | 1 | 1984 | 1424 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1996 | 1057 | 0.030 |
Why?
|
| Nitroprusside | 1 | 1995 | 272 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 1999 | 771 | 0.030 |
Why?
|
| Back | 1 | 1995 | 64 | 0.030 |
Why?
|
| Sarcoma, Experimental | 1 | 1995 | 117 | 0.030 |
Why?
|
| Intestine, Large | 1 | 1994 | 69 | 0.030 |
Why?
|
| Colonic Neoplasms | 2 | 2000 | 2543 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2001 | 14484 | 0.030 |
Why?
|
| Protein Precursors | 1 | 1998 | 1135 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 2 | 1994 | 911 | 0.030 |
Why?
|
| Length of Stay | 4 | 1999 | 6526 | 0.030 |
Why?
|
| Neoplasms, Second Primary | 1 | 2002 | 1060 | 0.030 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1981 | 807 | 0.030 |
Why?
|
| Ion Channels | 2 | 2013 | 1043 | 0.030 |
Why?
|
| Blood Pressure | 8 | 1984 | 8544 | 0.030 |
Why?
|
| Peptide YY | 1 | 1994 | 135 | 0.030 |
Why?
|
| Postoperative Period | 2 | 2002 | 1830 | 0.030 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1995 | 304 | 0.030 |
Why?
|
| Stomach | 1 | 1998 | 702 | 0.030 |
Why?
|
| Acid-Base Equilibrium | 2 | 1984 | 180 | 0.030 |
Why?
|
| Brain Chemistry | 1 | 1997 | 959 | 0.030 |
Why?
|
| Culture Media | 2 | 1986 | 898 | 0.030 |
Why?
|
| Mastectomy, Modified Radical | 1 | 1993 | 62 | 0.030 |
Why?
|
| Carbon Radioisotopes | 3 | 1993 | 567 | 0.030 |
Why?
|
| Lipolysis | 1 | 2014 | 211 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2016 | 2056 | 0.030 |
Why?
|
| Nerve Growth Factors | 1 | 1996 | 564 | 0.030 |
Why?
|
| Morbidity | 1 | 1999 | 1757 | 0.030 |
Why?
|
| Adenocarcinoma | 3 | 2011 | 6401 | 0.030 |
Why?
|
| Mitochondrial Proteins | 2 | 2013 | 980 | 0.030 |
Why?
|
| Biopsy | 3 | 1999 | 6805 | 0.030 |
Why?
|
| Duodenum | 1 | 1976 | 495 | 0.030 |
Why?
|
| Carbon Dioxide | 1 | 1997 | 1149 | 0.030 |
Why?
|
| Aspartate Aminotransferases | 4 | 1993 | 414 | 0.030 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 1996 | 572 | 0.030 |
Why?
|
| Cardiac Output | 3 | 1984 | 838 | 0.030 |
Why?
|
| Adolescent | 6 | 2016 | 89244 | 0.030 |
Why?
|
| Microtubules | 1 | 1998 | 1062 | 0.030 |
Why?
|
| Young Adult | 2 | 2016 | 60131 | 0.030 |
Why?
|
| Gastroenterology | 1 | 1999 | 593 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2003 | 4179 | 0.020 |
Why?
|
| Adjuvants, Immunologic | 1 | 1997 | 999 | 0.020 |
Why?
|
| Pyridines | 1 | 2004 | 2895 | 0.020 |
Why?
|
| Immunohistochemistry | 3 | 2002 | 11116 | 0.020 |
Why?
|
| Adipose Tissue | 2 | 2014 | 3335 | 0.020 |
Why?
|
| Brain | 2 | 1997 | 27453 | 0.020 |
Why?
|
| Cross Infection | 1 | 1981 | 1425 | 0.020 |
Why?
|
| Laparotomy | 2 | 1984 | 459 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 1992 | 575 | 0.020 |
Why?
|
| Sensitivity and Specificity | 3 | 2005 | 14752 | 0.020 |
Why?
|
| Cell Separation | 1 | 1997 | 1728 | 0.020 |
Why?
|
| Glucose | 4 | 1997 | 4352 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 1993 | 963 | 0.020 |
Why?
|
| Survival Rate | 2 | 2004 | 12873 | 0.020 |
Why?
|
| Solutions | 2 | 1988 | 410 | 0.020 |
Why?
|
| Cholecystitis | 2 | 1999 | 181 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2000 | 3659 | 0.020 |
Why?
|
| Myocardium | 3 | 1997 | 4790 | 0.020 |
Why?
|
| Drug Synergism | 1 | 1994 | 1762 | 0.020 |
Why?
|
| Breast Diseases | 1 | 1993 | 442 | 0.020 |
Why?
|
| Maleates | 1 | 1990 | 18 | 0.020 |
Why?
|
| Liver Glycogen | 1 | 1990 | 36 | 0.020 |
Why?
|
| Guinea Pigs | 2 | 1996 | 1309 | 0.020 |
Why?
|
| Membrane Potentials | 2 | 1984 | 1090 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2003 | 4939 | 0.020 |
Why?
|
| DNA Probes | 1 | 1991 | 543 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2002 | 3968 | 0.020 |
Why?
|
| Cobalt | 1 | 1990 | 148 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1994 | 1340 | 0.020 |
Why?
|
| Eating | 4 | 1990 | 1542 | 0.020 |
Why?
|
| Probability | 1 | 1995 | 2483 | 0.020 |
Why?
|
| Extremities | 1 | 1995 | 870 | 0.020 |
Why?
|
| Hyperplasia | 1 | 1992 | 1154 | 0.020 |
Why?
|
| Myosins | 1 | 1991 | 408 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1991 | 1305 | 0.020 |
Why?
|
| Apoptosis | 1 | 2005 | 9527 | 0.020 |
Why?
|
| Arachidonic Acid | 1 | 1990 | 429 | 0.020 |
Why?
|
| Pancreas | 1 | 1976 | 1700 | 0.020 |
Why?
|
| Monokines | 1 | 1988 | 71 | 0.020 |
Why?
|
| Inflammation | 2 | 2000 | 10868 | 0.020 |
Why?
|
| Free Radicals | 1 | 1988 | 238 | 0.020 |
Why?
|
| Catalase | 1 | 1988 | 215 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2021 | 3591 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2000 | 10115 | 0.020 |
Why?
|
| Alanine Transaminase | 3 | 1992 | 606 | 0.020 |
Why?
|
| Drug Therapy, Combination | 2 | 1988 | 6320 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2014 | 1855 | 0.020 |
Why?
|
| Body Water | 1 | 1988 | 340 | 0.020 |
Why?
|
| Risk | 3 | 1984 | 9621 | 0.020 |
Why?
|
| Endopeptidases | 1 | 1991 | 764 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2000 | 3840 | 0.020 |
Why?
|
| Laparoscopy | 1 | 1999 | 2055 | 0.020 |
Why?
|
| Orosomucoid | 3 | 1992 | 45 | 0.020 |
Why?
|
| Infusions, Intravenous | 2 | 1989 | 2231 | 0.020 |
Why?
|
| Cell Division | 1 | 1994 | 4478 | 0.020 |
Why?
|
| Peripheral Nerves | 1 | 1970 | 492 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 1999 | 5151 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 15951 | 0.020 |
Why?
|
| Neoplasm Transplantation | 2 | 2004 | 2018 | 0.020 |
Why?
|
| Follow-Up Studies | 4 | 2021 | 39394 | 0.020 |
Why?
|
| Age Factors | 6 | 2002 | 18435 | 0.020 |
Why?
|
| Goiter, Nodular | 1 | 1986 | 28 | 0.020 |
Why?
|
| Adipocytes | 1 | 2013 | 1199 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2013 | 2732 | 0.020 |
Why?
|
| Mutation | 2 | 2002 | 30266 | 0.020 |
Why?
|
| Toxins, Biological | 1 | 1986 | 59 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 1980 | 2974 | 0.020 |
Why?
|
| Chromones | 1 | 2005 | 148 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 1988 | 556 | 0.020 |
Why?
|
| Radiography | 4 | 1983 | 6991 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 1990 | 1209 | 0.020 |
Why?
|
| Intracellular Fluid | 1 | 1985 | 201 | 0.020 |
Why?
|
| Clinical Trials as Topic | 3 | 1987 | 8055 | 0.020 |
Why?
|
| Drainage | 2 | 1981 | 1184 | 0.010 |
Why?
|
| Antisepsis | 1 | 1984 | 16 | 0.010 |
Why?
|
| Calcinosis | 1 | 1993 | 1479 | 0.010 |
Why?
|
| Phosphocreatine | 3 | 1992 | 261 | 0.010 |
Why?
|
| Linear Models | 1 | 1995 | 5891 | 0.010 |
Why?
|
| Heart Rate | 3 | 1986 | 4217 | 0.010 |
Why?
|
| Adrenalectomy | 3 | 1993 | 348 | 0.010 |
Why?
|
| Salicylates | 1 | 2004 | 128 | 0.010 |
Why?
|
| Diaphragm | 1 | 1986 | 357 | 0.010 |
Why?
|
| Torsion Abnormality | 1 | 1984 | 92 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2013 | 2576 | 0.010 |
Why?
|
| Abdomen, Acute | 1 | 1984 | 122 | 0.010 |
Why?
|
| Parenteral Nutrition | 1 | 1988 | 663 | 0.010 |
Why?
|
| Hepatectomy | 1 | 1987 | 588 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1980 | 4363 | 0.010 |
Why?
|
| Tryptophan | 1 | 1986 | 482 | 0.010 |
Why?
|
| Pyruvic Acid | 2 | 1996 | 205 | 0.010 |
Why?
|
| Kidney | 1 | 1999 | 7058 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1985 | 565 | 0.010 |
Why?
|
| I-kappa B Kinase | 1 | 2004 | 250 | 0.010 |
Why?
|
| Actins | 1 | 1991 | 2065 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2016 | 8748 | 0.010 |
Why?
|
| Mammaplasty | 1 | 1993 | 1263 | 0.010 |
Why?
|
| Clinical Competence | 1 | 1999 | 4860 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1986 | 2560 | 0.010 |
Why?
|
| Fever | 1 | 1990 | 1619 | 0.010 |
Why?
|
| Morpholines | 1 | 2005 | 584 | 0.010 |
Why?
|
| Magnesium Chloride | 1 | 1982 | 30 | 0.010 |
Why?
|
| Blood Vessel Prosthesis | 2 | 1984 | 957 | 0.010 |
Why?
|
| Portal Vein | 1 | 1985 | 435 | 0.010 |
Why?
|
| Regional Blood Flow | 2 | 1983 | 1500 | 0.010 |
Why?
|
| Neurotransmitter Agents | 1 | 1986 | 663 | 0.010 |
Why?
|
| Creatinine | 1 | 1987 | 1917 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2003 | 394 | 0.010 |
Why?
|
| Mice, Inbred ICR | 1 | 2002 | 363 | 0.010 |
Why?
|
| Bronchopneumonia | 1 | 1981 | 11 | 0.010 |
Why?
|
| Acute Disease | 3 | 1999 | 7245 | 0.010 |
Why?
|
| Rhodamines | 1 | 2001 | 178 | 0.010 |
Why?
|
| Water-Electrolyte Balance | 1 | 1982 | 326 | 0.010 |
Why?
|
| Keratins | 1 | 2002 | 502 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 1984 | 939 | 0.010 |
Why?
|
| Lipoma | 1 | 1983 | 296 | 0.010 |
Why?
|
| Acetylcholinesterase | 2 | 1970 | 151 | 0.010 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1984 | 746 | 0.010 |
Why?
|
| Rupture | 1 | 1981 | 444 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2021 | 65480 | 0.010 |
Why?
|
| Aging | 1 | 1999 | 8745 | 0.010 |
Why?
|
| Polyribosomes | 1 | 1980 | 109 | 0.010 |
Why?
|
| Veins | 1 | 1984 | 769 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2001 | 521 | 0.010 |
Why?
|
| Edema | 1 | 1984 | 766 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2021 | 24333 | 0.010 |
Why?
|
| Quality of Life | 1 | 2021 | 13510 | 0.010 |
Why?
|
| Pulmonary Atelectasis | 1 | 1981 | 160 | 0.010 |
Why?
|
| Candidiasis | 1 | 2002 | 367 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 1984 | 1056 | 0.010 |
Why?
|
| Oxidants | 1 | 2000 | 168 | 0.010 |
Why?
|
| Digestive System Diseases | 1 | 1981 | 152 | 0.010 |
Why?
|
| Swine | 3 | 1987 | 5997 | 0.010 |
Why?
|
| Biological Products | 1 | 1988 | 947 | 0.010 |
Why?
|
| Free Radical Scavengers | 1 | 2000 | 213 | 0.010 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2000 | 251 | 0.010 |
Why?
|
| Acyltransferases | 2 | 1970 | 306 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 1992 | 3982 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2013 | 22379 | 0.010 |
Why?
|
| Sirolimus | 1 | 2005 | 1540 | 0.010 |
Why?
|
| Blood Glucose | 5 | 1991 | 6435 | 0.010 |
Why?
|
| Biliary Tract Diseases | 1 | 1999 | 159 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1987 | 1892 | 0.010 |
Why?
|
| Blood Volume | 1 | 1979 | 546 | 0.010 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1983 | 735 | 0.010 |
Why?
|
| Monensin | 1 | 1996 | 30 | 0.010 |
Why?
|
| Urinary Fistula | 1 | 1977 | 44 | 0.010 |
Why?
|
| Aerobiosis | 1 | 1996 | 100 | 0.010 |
Why?
|
| Sex Factors | 2 | 1982 | 10633 | 0.010 |
Why?
|
| Intestinal Polyps | 1 | 1977 | 105 | 0.010 |
Why?
|
| Suture Techniques | 1 | 1981 | 779 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2005 | 2063 | 0.010 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 1996 | 77 | 0.010 |
Why?
|
| Spleen | 1 | 2002 | 2294 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2013 | 11684 | 0.010 |
Why?
|
| Radiotherapy | 1 | 2002 | 1506 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1993 | 9442 | 0.010 |
Why?
|
| Cohort Studies | 1 | 1997 | 41808 | 0.010 |
Why?
|
| Fluorouracil | 1 | 1979 | 1655 | 0.010 |
Why?
|
| Intestinal Neoplasms | 1 | 1977 | 314 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2002 | 2916 | 0.010 |
Why?
|
| Alanine | 1 | 1996 | 614 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2002 | 2252 | 0.010 |
Why?
|
| Mastectomy, Simple | 1 | 1993 | 23 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2002 | 3629 | 0.010 |
Why?
|
| Mastectomy | 1 | 2002 | 1850 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 1995 | 825 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 1984 | 4926 | 0.010 |
Why?
|
| Axonal Transport | 2 | 1970 | 178 | 0.010 |
Why?
|
| Abscess | 1 | 1977 | 606 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 1981 | 1430 | 0.010 |
Why?
|
| Weight Gain | 2 | 1995 | 2359 | 0.010 |
Why?
|
| Research Design | 1 | 1988 | 6214 | 0.010 |
Why?
|
| Hypoglossal Nerve | 2 | 1970 | 110 | 0.010 |
Why?
|
| Glycolysis | 1 | 1996 | 838 | 0.010 |
Why?
|
| Vascular Diseases | 1 | 1981 | 1163 | 0.010 |
Why?
|
| Potassium | 1 | 1996 | 1315 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 9565 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1996 | 2488 | 0.010 |
Why?
|
| Antioxidants | 1 | 2000 | 1673 | 0.010 |
Why?
|
| Pyruvates | 1 | 1991 | 83 | 0.010 |
Why?
|
| Immune Sera | 1 | 1992 | 605 | 0.010 |
Why?
|
| Bile | 1 | 1992 | 299 | 0.010 |
Why?
|
| Colectomy | 1 | 1977 | 699 | 0.010 |
Why?
|
| Sodium | 1 | 1996 | 1597 | 0.010 |
Why?
|
| Vagus Nerve | 2 | 1970 | 460 | 0.010 |
Why?
|
| Cytoplasmic Streaming | 1 | 1970 | 5 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 1996 | 1191 | 0.010 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1990 | 71 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 1970 | 292 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2002 | 3473 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2002 | 8559 | 0.010 |
Why?
|
| Catecholamines | 1 | 1991 | 389 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1984 | 12467 | 0.010 |
Why?
|
| Calcium Radioisotopes | 1 | 1989 | 9 | 0.010 |
Why?
|
| Cranial Nerves | 1 | 1970 | 98 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 1970 | 458 | 0.010 |
Why?
|
| Autoradiography | 1 | 1970 | 728 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 1 | 1989 | 189 | 0.010 |
Why?
|
| Learning | 1 | 1999 | 1760 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2005 | 6673 | 0.000 |
Why?
|
| Parenteral Nutrition Solutions | 1 | 1988 | 30 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1991 | 1629 | 0.000 |
Why?
|
| Peritoneal Cavity | 1 | 1989 | 135 | 0.000 |
Why?
|
| Verapamil | 1 | 1989 | 242 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2005 | 9080 | 0.000 |
Why?
|
| Organ Culture Techniques | 1 | 1991 | 796 | 0.000 |
Why?
|
| Menopause | 1 | 1977 | 1656 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1996 | 2614 | 0.000 |
Why?
|
| Glycogen | 1 | 1989 | 252 | 0.000 |
Why?
|
| Electrolytes | 1 | 1988 | 279 | 0.000 |
Why?
|
| Neoplasm Proteins | 1 | 1980 | 3608 | 0.000 |
Why?
|
| Blood | 1 | 1990 | 599 | 0.000 |
Why?
|
| Rabbits | 2 | 1970 | 4774 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1988 | 657 | 0.000 |
Why?
|
| Foot | 1 | 1991 | 577 | 0.000 |
Why?
|
| Transferrin | 1 | 1988 | 284 | 0.000 |
Why?
|
| Blood Transfusion | 1 | 1993 | 1309 | 0.000 |
Why?
|
| Phenotype | 1 | 2004 | 16731 | 0.000 |
Why?
|
| Suction | 1 | 1987 | 268 | 0.000 |
Why?
|
| Prostheses and Implants | 1 | 1993 | 1279 | 0.000 |
Why?
|
| Drug Evaluation | 1 | 1987 | 642 | 0.000 |
Why?
|
| Rest | 1 | 1991 | 951 | 0.000 |
Why?
|
| Drug Interactions | 1 | 1990 | 1418 | 0.000 |
Why?
|
| Ultrasonic Therapy | 1 | 1987 | 217 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 36854 | 0.000 |
Why?
|
| Platelet Count | 1 | 1987 | 787 | 0.000 |
Why?
|
| Surgical Flaps | 1 | 1993 | 1682 | 0.000 |
Why?
|
| Lymph | 1 | 1984 | 78 | 0.000 |
Why?
|
| Blood Transfusion, Autologous | 1 | 1984 | 130 | 0.000 |
Why?
|
| Endarterectomy | 1 | 1984 | 196 | 0.000 |
Why?
|
| Glucosephosphates | 1 | 1982 | 19 | 0.000 |
Why?
|
| Glucose-6-Phosphate | 1 | 1982 | 29 | 0.000 |
Why?
|
| Registries | 1 | 1999 | 8384 | 0.000 |
Why?
|
| Cholelithiasis | 1 | 1984 | 408 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2005 | 20776 | 0.000 |
Why?
|
| Axons | 1 | 1970 | 1678 | 0.000 |
Why?
|
| Hydrocortisone | 1 | 1990 | 1841 | 0.000 |
Why?
|
| Abdomen | 1 | 1988 | 1137 | 0.000 |
Why?
|
| Laser Therapy | 1 | 1987 | 1110 | 0.000 |
Why?
|
| Pressure | 1 | 1984 | 1172 | 0.000 |
Why?
|
| Capillary Permeability | 1 | 1984 | 773 | 0.000 |
Why?
|
| Microchemistry | 1 | 1979 | 55 | 0.000 |
Why?
|
| Electrophoresis | 1 | 1979 | 226 | 0.000 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1979 | 293 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1993 | 11262 | 0.000 |
Why?
|
| Pregnancy | 1 | 1980 | 30265 | 0.000 |
Why?
|
| Child | 2 | 1983 | 80960 | 0.000 |
Why?
|
| Coronary Artery Bypass | 1 | 1984 | 2194 | 0.000 |
Why?
|
| Hospitalization | 1 | 1983 | 10847 | 0.000 |
Why?
|